A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse ModelsCELLSIF5.22022-10-317OAAI
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma携带p53基因的靶向肿瘤的纳米药物穿过血脑屏障并增强胶质母细胞瘤小鼠模型的anti-PD-1免疫治疗INTERNATIONAL JOURNAL OF CANCERIF4.72019-07-0862OAAI
Interactions of the 67 kDa laminin receptor and its precursor with lamininBIOSCIENCE REPORTSIF4.72009-11-1020OAAI
The 67 kDa laminin receptor: structure, function and role in diseaseBIOSCIENCE REPORTSIF4.72008-02-12187PREAI